# PAPULEX ## Facts | | | |---|---| | Origin | France | | Headquarters | Chippenham | | Status | Acquired | | Website | https://www.papulex.com/ | PAPULEX is a dermocosmetic skincare range for blemish-prone skin, made up of a cleanser, a toner, a spot treatment and two moisturisers. The brand presents itself as well-established in France and now in use around the world [1], and it says its formulas draw on more than 20 years of experience in managing blemishes. PAPULEX is not an independent company. It belongs to the Alliance Pharma group, which holds the PAPULEX trade mark [5] and whose office in Chippenham, in the United Kingdom, is the only address the brand publishes. The range remains on the market under that ownership, with a live website and five products in 2026. ## Origin Little is publicly documented about how PAPULEX began. Its founding year and founders remain unknown, and the brand's reference to "over 20 years' expertise" describes accumulated experience rather than a launch date. Who first developed the range, and when it first went on sale, has not been confirmed. What the brand does say about its roots points to France. Its website opens with a short self-introduction describing PAPULEX as a brand that is well-established there. A French medical product database supports that picture: it lists PAPULEX Crème, an anti-blemish cream for local application sold in a 40 ml tube, with Alliance Pharma France SAS as the company that markets it [9]. ## Ownership A notice on the brand's website states that PAPULEX, Alliance and the associated logos are registered trade marks of the Alliance Pharma Limited group [5]. The same site carries a copyright line in the name of Alliance Pharmaceuticals Limited, the group company behind the website. The brand's geography therefore has two sides. France is where PAPULEX describes itself as established and where a French Alliance subsidiary markets it. The United Kingdom is where its owner sits: the contact page gives Alliance Pharma plc in Chippenham, Wiltshire, as the brand's address [6]. This article treats France as the brand's home market and the UK address as that of its corporate owner, rather than as the brand's country of origin. ## Philosophy & positioning PAPULEX sits in dermocosmetics, skincare developed with a dermatological focus rather than a purely cosmetic one. According to the company, each product is designed specifically for blemish-prone skin while remaining suitable for all skin types. The range is built around a three-step routine of cleanse, tone and moisturise, which the brand describes as dermatologist-recommended. The brand's tagline is "Live Life Unfiltered". Its homepage links the slogan to the idea that people should not need photo filters, or creative make-up tricks, to hide their blemishes. PAPULEX says its "clinically proven combination of ingredients" helps clear existing blemishes, prevents new ones from forming and helps the skin return to its natural appearance [1]. Alongside its products, the website publishes a body of explanatory material on blemishes. Its question-and-answer section describes excess oil, or sebum, as the starting point of most breakouts. For adults it lists contributing factors such as changing hormones, stress, family history, some hair and skin care products, and side effects of medication. The brand takes a measured line on diet, stating that food alone neither causes nor prevents blemishes, while naming milk, sugary foods and chocolate as possible triggers. It also tells readers to see a doctor for severe cases or when over-the-counter products are not helping [4]. ## Products & ingredients The current range has five products, and the brand maps each one to a step of its routine or to a skin type. Moussant, a foaming gel, covers cleansing; the company says it purifies the skin and regulates oiliness. Lotion is a toner meant to tighten pores and keep oil in check. Gel is a targeted corrector that dries out individual spots. For the final step, PAPULEX splits its moisturisers by skin type. Oil-Free Cream is designed to hydrate oily skin without leaving it greasy and to help give a matte finish. Isocorrexion is aimed at dry skin; according to the brand, it reduces dryness and flaking while also helping to reduce blemishes. In the French medical database, PAPULEX Crème is classed as an anti-acne cream with anti-inflammatory, sebum-regulating and mattifying properties [9]. Three ingredients carry most of the brand's claims. The first is Defenskin, which PAPULEX describes as defending the skin while supporting its natural microbiome, the community of microbes that lives on its surface. Rather than killing bacteria, the brand explains, Defenskin is meant to stop them from sticking to the skin and settling in the pores. The company states that it reduces the adhesion of P. acnes bacteria, which it identifies as a cause of blemishes, by up to 97% [2]. For this figure the website cites a 2003 study by Rougier [3]. The second is niacinamide, which the brand calls "the skincare hero". PAPULEX says the ingredient has been shown to reduce the number of blemishes, and it credits niacinamide with calming redness, evening out skin tone and making pores look smaller. Its ingredient page lists studies from 2002 and 2014 in support. The third is Zincidone, a combination of zinc and pyrrolidone carboxylic acid (zinc PCA). The brand calls it "the skin oil controller" and says it limits oil production so that excess sebum does not block the pores. PAPULEX does not describe either Defenskin or Zincidone as its own development, and its reference for Zincidone is a 2008 report by Solabia [3]. ## Current status PAPULEX continues as a brand of the Alliance Pharma group rather than as a stand-alone business. Its most recent visible activity is its website, which in 2026 carried an Alliance Pharmaceuticals Limited copyright notice for that year and listed the full five-product range [1]. No newer launches or dated announcements from the brand are publicly recorded. The brand describes its reach in global terms, saying it is now helping to keep faces blemish-free all over the world. ## Timeline {#belagg-timeline} | Year | Event | Source | |---|---|---| | 2015 | Alliance Pharma plc announced (26 November 2015) a conditional agreement to acquire Sinclair IS Pharma plc's dermatology-focused Healthcare Products Business, in which Papulex™ is listed as an acne treatment product with sales of £1.8 million in the 12 months to 30 June 2015. | https://www.investegate.co.uk/announcement/rns/alliance-pharma--aph/proposed-acquisition/4247922 | | 2015 | Acquired by Alliance Pharma plc from Sinclair IS Pharma plc as part of the Healthcare Products Business (consideration £127.5 million plus est. £4.7 million inventory; announced 26 November 2015) | https://www.investegate.co.uk/announcement/rns/alliance-pharma--aph/proposed-acquisition/4247922 | ## Signature products {#belagg-products} - **Papulex™ Moussant** — Our pore-cleansing anti-blemish foaming gel — https://www.papulex.com/our-products/ - **Papulex™ Lotion** — Our pore-minimising anti-blemish toner — https://www.papulex.com/our-products/ - **Papulex™ Gel** — Our targeted blemish corrector — https://www.papulex.com/our-products/ - **Papulex™ Oil-Free Cream** — Our anti-blemish hydrating skin moisturiser for oily skin — https://www.papulex.com/our-products/ - **Papulex™ Isocorrexion** — Our anti-blemish intense dehydration fighter for dry skin — https://www.papulex.com/our-products/ ## Key ingredients {#belagg-ingredients} Defenskin™ · Niacinamide · Zincidone® (zinc PCA) Source: https://www.papulex.com/ ## Sources 1. (T1) https://www.papulex.com/ 2. (T1) https://www.papulex.com/how-papulex-works/ 3. (T2) https://www.papulex.com/ingredient-spotlight/ 4. (T2) https://www.papulex.com/faq/ 5. (T2) https://www.papulex.com/our-products/ 6. (T2) https://www.papulex.com/contact/ 9. (T4) https://www.lequotidiendumedecin.fr/bcb/produit/129758/nom/PAPULEX%20CR%C3%88ME%20-%20Cr%C3%A8me%20antiacn%C3%A9ique%2C%20antiinflammatoire%2C%20s%C3%A9bor%C3%A9gulatrice%20et%20matifiante.%20%20-%20tube%2040%20ml --- Glowpedia · · Published 2026-10-06 Please cite with a link to the article URL.